Related Experiment Video

Updated: May 30, 2026

Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future

Agnieszka K Witkiewicz1, Karen E Knudsen, Adam P Dicker

  • 1Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

Cell Cycle (Georgetown, Tex.)
|July 22, 2011
PubMed

Insights

The CDKN2A gene

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The CDKN2A gene encodes the CDK4/6 inhibitor p16(ink4a), a critical tumor suppressor.
  • Loss of p16(ink4a) function can lead to uncontrolled cell proliferation and malignant progression.
  • Paradoxically, high p16(ink4a) expression in tumors often correlates with aggressive disease and impacts prognosis.

Purpose of the Study:

  • To clarify the complex roles of p16(ink4a) in tumor pathobiology.
  • To explore the implications of p16(ink4a) expression in understanding tumor heterogeneity.
  • To identify p16(ink4a) as a potential marker for therapeutic strategies.

Main Methods:

  • Literature review of studies investigating CDKN2A gene and p16(ink4a) expression.
  • Analysis of the relationship between p16(ink4a) levels and tumor progression.
  • Examination of p16(ink4a) as a biomarker in various clinical settings.

Main Results:

  • The dual role of p16(ink4a) in tumor suppression and association with aggressive disease subtypes is highlighted.
  • Elevated p16(ink4a) expression is a significant factor in disease prognosis and therapeutic response.
  • The contradictory findings regarding p16(ink4a) expression have caused confusion in understanding its role.

Conclusions:

  • p16(ink4a) expression serves as a valuable indicator of RB-pathway function.
  • Alternative p16(ink4a) expression patterns can reflect tumor heterogeneity.
  • Understanding p16(ink4a) dynamics offers novel avenues for directing cancer therapies.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...